Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
19.41
-1.54 (-7.35%)
Nov 2, 2026, 4:00 PM EST - Market closed
Anika Therapeutics Market Cap
Anika Therapeutics has a market cap or net worth of $259.76 million as of November 2, 2026. It is the 18,930th most valuable company in the world and the 3,329th biggest in the United States. Its market cap has increased by 84.75% in one year.
Market Cap
259.76M
Enterprise Value
246.60M
1-Year Change
84.75%
Global Rank
Country Rank
#3,329 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $259.76M, an increase of 407.35%. That is a compound annual growth rate of 5.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 259.76M | 87.42% |
| Dec 31, 2025 | 138.60M | -42.51% |
| Dec 31, 2024 | 241.10M | -27.34% |
| Dec 29, 2023 | 331.80M | -23.27% |
| Dec 30, 2022 | 432.40M | -16.41% |
| Dec 31, 2021 | 517.30M | -19.59% |
| Dec 31, 2020 | 643.30M | -13.06% |
| Dec 31, 2019 | 739.90M | 54.92% |
| Dec 31, 2018 | 477.60M | -39.57% |
| Dec 29, 2017 | 790.40M | 10.39% |
| Dec 30, 2016 | 716.00M | 28.18% |
| Dec 31, 2015 | 558.60M | -5.47% |
| Dec 31, 2014 | 590.90M | 12.00% |
| Dec 31, 2013 | 527.60M | 284.27% |
| Dec 31, 2012 | 137.30M | 2.85% |
| Dec 30, 2011 | 133.50M | 48.50% |
| Dec 31, 2010 | 89.90M | 2.98% |
| Dec 31, 2009 | 87.30M | 152.31% |
| Dec 31, 2008 | 34.60M | -78.71% |
| Dec 31, 2007 | 162.50M | 14.12% |
| Dec 29, 2006 | 142.40M | 16.06% |
| Dec 30, 2005 | 122.70M | 31.51% |
| Dec 31, 2004 | 93.30M | -4.11% |
| Dec 31, 2003 | 97.30M | 892.86% |
| Dec 31, 2002 | 9.80M | -1.01% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kamada | 447.24M |
| Tilray Brands | 371.06M |
| Emergent BioSolutions | 349.17M |
| Canopy Growth | 281.97M |
| BioAge Labs | 269.41M |
| Aurora Cannabis | 266.70M |
| Lifecore Biomedical | 242.26M |
| SIGA Technologies | 218.42M |